iso4217:GBP
xbrli:pure
xbrli:shares
iso4217:GBP
xbrli:shares
SC049527
2025-11-30
SC049527
2024-11-30
SC049527
2024-12-01
2025-11-30
SC049527
2023-12-01
2024-11-30
SC049527
bus:Micro-entities
2024-12-01
2025-11-30
SC049527
bus:AuditExemptWithAccountantsReport
2024-12-01
2025-11-30
SC049527
bus:FilletedAccounts
2024-12-01
2025-11-30
SC049527
bus:SmallCompaniesRegimeForAccounts
2024-12-01
2025-11-30
SC049527
bus:Director1
2024-12-01
2025-11-30
SC049527
2024-12-01
2025-11-30
SC049527
bus:PrivateLimitedCompanyLtd
2024-12-01
2025-11-30
Medlaw Properties Limited
Registration Number SC049527 (Scotland)
Filleted Unaudited Financial Statements
for the year ended 30 November 2025
Medlaw Properties Limited
Filleted Financial Statements for the year ended 30 November 2025
Fixed assets
7,050,342
6,770,188
Current assets
516,533
374,882
Creditors: amounts falling due within one year
(101,215)
(67,247)
Net current assets
415,318
307,635
Total assets less current liabilities
7,465,660
7,077,823
Net assets
7,465,660
7,077,823
Capital and reserves
7,465,660
7,077,823
Notes to the financial statements
The average number of employees, including directors, during the year was as follows:
2.
Directors' benefits: advances, credit and guarantees
As at 30 November 2025, £5,407 (2024 - £62,374 owed by the directors) was owed to the directors. There are no fixed terms of repayment and interest is charged at the rates advised by HMRC.
For the year ended 30 November 2025, the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Directors' responsibilties:
•
The member has not required the company to obtain an audit of its financial statements for the year ended 30 November 2025 in accordance with section 476 of the Companies Act 2006.
•
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These financial statements have been prepared in accordance with the micro-entity regime and have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.
The financial statements were approved and authorised for issue by the Board of Directors on 26 April 2026.
Medlaw Properties Limited
Filleted Financial Statements for the year ended 30 November 2025
Appendix - Additional XBRL Tags and Values
Accounting standards applied
Accounts status, audited or unaudited
Average number of employees during the period
Average number of employees during the period
Date of authorisation of financial statements for issue
Description of principal activities
principal activity during the year was the holding of investments.
Director signing Directors' Report
Director signing financial statements
End date for period covered by report
Entity current legal or registered name
Medlaw Properties Limited
Entity is dormant [true/false]
Equity [Multiple Tags or Values]
Equity [Multiple Tags or Values]
Name of production software
Start date for period covered by report
Trade creditors / trade payables [Multiple Tags or Values]
Trade creditors / trade payables [Multiple Tags or Values]
UK Companies House registered number
Version of production software